Advanced Translational Research on Childhood Leukemia
Recruiting now
Conditions studied: Childhood Leukemia
In brief
Prognosis of children with leukemia, the most common pediatric cancer, has improved markedly. Yet, relapse still occurs in 15-40% of patients with a probability of survival of \<50%, which is unlikely to be boosted by intensification of standard chemotherapy due to overwhelming toxicity. The advent of effective and safe targeted therapies for high-risk cases is therefore imperative. This study constitutes two research projects aiming at driving therapeutic advances.
Key facts
- Study ID
- NCT04478006
- Run by
- Chinese University of Hong Kong
- People needed
- 300
- Starts
- 2020-07-01
- Expected to finish
- 2028-06-01
- Last updated by the study team
- 2026-02-03
Who can join
Age: any, up to 18. Sex: any. Healthy volunteers: accepted.
Where it is running
- Hong Kong Children Hospital — Hong Kong, Hksar, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.